AZD8529 Single Ascending Dose Study in Healthy Japanese Subjects - JSAD

Study identifier:D1960C00003

ClinicalTrials.gov identifier:N/A

EudraCT identifier:2009-009940-22

CTIS identifier:N/A

Study Complete

Official Title

A Phase I, Single-Centre, Randomised, Double-Blind, Placebo Controlled Single-Ascending Dose, Study to Assess the Safety, Tolerability, Pharmacokinetics of AZD8529 in Healthy Male Japanese Subjects

Medical condition

Healthy

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD8529, Placebo

Sex

Male

Actual Enrollment

48

Study type

Interventional

Age

20 Years - 45 Years

Date

Study Start Date: 01 Apr 2009
Primary Completion Date: -
Study Completion Date: 01 Jul 2009

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Basic Science

Verification:

Verified 01 Aug 2009 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria